Sponsor of the Day:
Jerkmate
https://www.benzinga.com/news/26/04/51666050/jp-morgan-maintains-neutral-on-agios-pharmaceuticals-raises-price-target-to-36
JP Morgan Maintains Neutral on Agios Pharmaceuticals, Raises Price Target to $36 - Agios...
Apr 6, 2026 - JP Morgan analyst Tessa Romero maintains Agios Pharmaceuticals (NASDAQ:AGIO) with a Neutral and raises the price target from $31 to $36.
raises price targetjp morganmaintains neutralagiospharmaceuticals
https://www.benzinga.com/news/26/04/52047471/ubs-maintains-neutral-on-heartland-express-raises-price-target-to-12
UBS Maintains Neutral on Heartland Express, Raises Price Target to $12 - Heartland Express...
Apr 24, 2026 - UBS analyst Thomas Wadewitz maintains Heartland Express (NASDAQ:HTLD) with a Neutral and raises the price target from $11 to $12.
raises price targetubs maintainsheartland expressneutral12
https://www.benzinga.com/news/26/04/52048032/macquarie-maintains-neutral-on-boyd-gaming-raises-price-target-to-95
Macquarie Maintains Neutral on Boyd Gaming, Raises Price Target to $95 - Boyd Gaming (NYSE:BYD) -...
Apr 24, 2026 - Macquarie analyst Chad Beynon maintains Boyd Gaming (NYSE:BYD) with a Neutral and raises the price target from $92 to $95.
raises price targetmaintains neutralboyd gamingnyse bydmacquarie
https://www.benzinga.com/news/26/04/51665536/goldman-sachs-maintains-neutral-on-acuity-lowers-price-target-to-295
Goldman Sachs Maintains Neutral on Acuity, Lowers Price Target to $295 - Acuity (NYSE:AYI) -...
Apr 6, 2026 - Goldman Sachs analyst Brian Lee maintains Acuity (NYSE:AYI) with a Neutral and lowers the price target from $342 to $295.
lowers price targetgoldman sachsmaintains neutralacuity295